CIK 0000885725
- Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042695240
- Phone
- +1 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-01 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Shares withheld for taxes | −605 | $43.60 | $26K | 17,830 |
| 2021-05-01 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion · Deferred Stock Units | −2,061 | 4,124 | ||
| 2021-04-30 | Sorenson John Bradley SVP, Manuf & Sup Chn | Sale | −3,572 | $43.51 | $155K | 46,920 |
| 2021-04-30 | Sorenson John Bradley SVP, Manuf & Sup Chn | Gift | −1,786 | 45,134 | ||
| 2021-04-30 | Carruthers Wendy SVP, Human Resources | Sale | −13,750 | $43.72 | $601K | 180,217 |
| 2021-04-30 | Carruthers Wendy SVP, Human Resources | Gift | −2,358 | 177,859 | ||
| 2021-04-28 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion | +48,439 | $7.39 | $358K | 187,597 |
| 2021-04-28 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Sale | −48,439 | $43.98 | $2.1M | 139,158 |
| 2021-04-28 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion · Stock Option (Right to Buy) | −48,439 | 0 | ||
| 2021-04-15 | Butcher Arthur C EVP&Pres, Asia Pacific | Exercise or conversion | +4,250 | $13.08 | $56K | 39,074 |
| 2021-04-15 | Butcher Arthur C EVP&Pres, Asia Pacific | Sale | −9,676 | $40.00 | $387K | 29,398 |
| 2021-04-15 | Butcher Arthur C EVP&Pres, Asia Pacific | Exercise or conversion · Stock Option (Right to Buy) | −4,250 | 4,250 | ||
| 2021-04-15 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion | +28,123 | $6.28 | $177K | 167,281 |
| 2021-04-15 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Sale | −28,123 | $40.95 | $1.2M | 139,158 |
| 2021-04-15 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion · Stock Option (Right to Buy) | −28,123 | 0 | ||
| 2021-04-01 | Olson Scott SVP & Pres, Rhythm Management | Sale | −700 | $38.61 | $27K | 12,844 |
| 2021-03-16 | Pierce David A EVP Pres MedSurg | Sale | −7,603 | $39.36 | $299K | 2,057 |
| 2021-03-03 | Fitzgerald Joseph Michael EVP & Pres, Interven Cardio | Exercise or conversion | +3,603 | 252,559 | ||
| 2021-03-03 | Fitzgerald Joseph Michael EVP & Pres, Interven Cardio | Shares withheld for taxes | −1,779 | $38.82 | $69K | 250,780 |
| 2021-03-03 | Fitzgerald Joseph Michael EVP & Pres, Interven Cardio | Exercise or conversion · Deferred Stock Units | −3,603 | 3,603 |
Page 93 of 104 · 2,069 trades